NASDAQ
Landos Biopharma, Inc. (LABP) has a current ratio of 6.09x as of Tuesday, May 26, 2026. This represents a 24.40% decrease compared to its 12-month average of 8.05x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.